KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Non Operating Income: 2021-2025

Historic Non Operating Income for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to $9.3 million.

  • Ginkgo Bioworks Holdings' Non Operating Income rose 688.50% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 146.70%. This contributed to the annual value of $12.2 million for FY2024, which is 142.93% up from last year.
  • As of Q3 2025, Ginkgo Bioworks Holdings' Non Operating Income stood at $9.3 million, which was up 86.83% from $5.0 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' 5-year Non Operating Income high stood at $82.6 million for Q1 2022, and its period low was -$75.9 million during Q3 2021.
  • Its 3-year average for Non Operating Income is -$360,455, with a median of $5.0 million in 2025.
  • Its Non Operating Income has fluctuated over the past 5 years, first tumbled by 552.20% in 2022, then soared by 688.50% in 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Non Operating Income (Quarterly) stood at $79.1 million in 2021, then plummeted by 45.59% to $43.0 million in 2022, then slumped by 178.52% to -$33.8 million in 2023, then skyrocketed by 87.41% to -$4.3 million in 2024, then surged by 688.50% to $9.3 million in 2025.
  • Its last three reported values are $9.3 million in Q3 2025, $5.0 million for Q2 2025, and -$1.9 million during Q1 2025.